New study combines Weight-Loss shot with virtual workouts for cancer survivors
NCT ID NCT07228741
Summary
This study is testing whether a weekly weight-loss medication (Tirzepatide) combined with a remote, supervised exercise program can help adult survivors of childhood leukemia lose weight and improve their heart and metabolic health. The 28-week program aims to see if participants can lose at least 5% of their body weight. The study is looking for 20 adult survivors who are at least 5 years from their leukemia diagnosis and have obesity or are overweight with a related health condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
St. Jude Children's Research Hospital
Memphis, Tennessee, 38105, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.